GOLDMAN SACHS GROUP INC - OMEGA THERAPEUTICS INC ownership

OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 59 filers reported holding OMEGA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$393,521
+388.6%
190,107
+761.5%
0.00%
Q1 2024$80,548
+106.2%
22,068
+70.0%
0.00%
Q4 2023$39,064
-8.6%
12,978
-34.7%
0.00%
Q3 2023$42,738
-55.3%
19,878
+16.4%
0.00%
Q2 2023$95,659
-69.1%
17,082
-66.7%
0.00%
Q1 2023$309,472
+228.4%
51,322
+210.9%
0.00%
Q4 2022$94,249
+98076.0%
16,506
-7.2%
0.00%
Q3 2022$96
+29.7%
17,780
-9.2%
0.00%
Q2 2022$74
-99.9%
19,576
-9.0%
0.00%
Q1 2022$134,000
-38.0%
21,521
+13.0%
0.00%
Q4 2021$216,00019,0510.00%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 25,902,269$293,472,7069.37%
HARBOURVEST PARTNERS LLC 2,647,059$15,114,7075.06%
CHI Advisors LLC 1,055,882$6,029,0851.61%
72 Investment Holdings, LLC 352,941$2,015,2930.93%
Artal Group S.A. 2,273,530$12,9820.72%
Oasis Management Co Ltd. 160,000$913,6000.18%
PLATINUM INVESTMENT MANAGEMENT LTD 583,738$3,333,1440.13%
STATE OF WISCONSIN INVESTMENT BOARD 1,857,265$10,604,9830.03%
RBF Capital, LLC 77,307$441,0000.03%
683 Capital Management, LLC 27,301$155,8890.01%
View complete list of OMEGA THERAPEUTICS INC shareholders